Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Emerge Weight Loss vs T2D.com

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

Emerge Weight Loss

Best for patients committed to tirzepatide as their drug of choice

Starting at $299/mo

CompoundedTirzepatideTelehealthPhysician supervised
Visit Emerge Weight Loss
6.1

T2D.com

Best for diabetic GLP-1 access

Starting at $999/mo

CompoundedSemaglutideTirzepatidePrescriber Included
Visit T2D.com

Side-by-Side Comparison

FeatureEmerge Weight LossT2D.com
Overall Score7.6/106.1/10
Starting Price$299/mo$999/mo
Customer Rating
Features4 features7 features
States Available501
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Emerge Weight Loss

Pros

  • Tirzepatide-focused (largest effect-size compounded GLP-1)
  • Wide dose range available
  • Physician-supervised telemedicine model

Cons

  • No semaglutide option — limits flexibility if tirzepatide tolerability is poor
  • Less brand recognition than Henry Meds, Mochi, or SkinnyRx

T2D.com

Pros

  • Built specifically for type 2 diabetic and pre-diabetic patients
  • Integrated service — prescriber, pharmacy, and delivery handled in one flow
  • Offers both compounded semaglutide and compounded tirzepatide
  • Temperature-controlled home delivery via UPS or FedEx
  • Ongoing prescriber monitoring and support included

Cons

  • No pricing published on the public website — must register to see costs
  • No states list published on the site
  • Newer brand with limited independent reviews
  • Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro

Our Verdict

Winner: Emerge Weight LossScore: 7.6/10

Emerge Weight Loss edges out T2D.com with a higher overall score of 7.6/10 and is particularly strong for patients committed to tirzepatide as their drug of choice. T2D.com remains a solid alternative, especially if you're looking for diabetic GLP-1 access.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.